James Patrick Tursi, Chief Medical Officer at Aralez Pharmaceuticals Inc. (ARLZ), sold 5,950 shares at $1.70 ($10K) on 2018-03-19, disclosed to the SEC on 2018-03-21.
Scheduled sale ($10k) by Chief Medical Officer under a pre-arranged 10b5-1 plan. Pre-set trade — not a discretionary signal on the stock.
Negative factors outweigh the positive ones.
| Filing → |
| ARLZ | BUY | 2017-03-17 | $10K | — | Filing → |
| ARLZ | BUY | 2016-05-23 | $38K | — | Filing → |
| ARLZ | BUY | 2016-05-18 | $17K | — | Filing → |